ClinicalTrials.Veeva

Menu

Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department.

L

Laval University

Status

Unknown

Conditions

COVID-19
Hyperoxia
Hypoxia
Hypoxemia

Treatments

Device: Automated oxygen titration

Study type

Observational

Funder types

Other

Identifiers

NCT05235386
FreeO2 COVID-19 urgence

Details and patient eligibility

About

The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department.

Full description

The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department. The quality of oxygen therapy is evaluated by the time spent in the SpO2 target (+/- 2% SpO2 target), time spent in hyperoxemia (> 5% SpO2 target), time spent in hyperoxemia (<5% SpO2 target).

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hypoxemic patients on automated oxygen therapy during their emergency department stay
  • Confirmed or suspected SARS-CoV-2 patients in the emergency department

Exclusion criteria

  • Patient on automated oxygen therapy in the emergency department without accessible data of the FreeO2 device.

Trial contacts and locations

1

Loading...

Central trial contact

Léa Dallaire, MD; François Lellouche, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems